SHINE – Systemic Hepatocellular carcinoma: Incorporating New Emerging therapies
November 28 @ 6:00 pm - 7:30 pm PST
You are cordially invited to SHINE – Systemic Hepatocellular carcinoma: Incorporating New Emerging therapies. A multidisciplinary virtual case-based discussion comprised of leading experts across Western Canada.
Thurs Nov 28 2024, 6-730 PST | 7-8:30 MST | 8-9:30 CST
Panelists
- Dr Michael Bleszynski, HPB Surgeon at Vancouver General Hospital – Vancouver
- Dr Mayur Brahmania, Hepatologist at University of Calgary and CASL’s Education Committee Co-Chair – Calgary
- Dr Howard Lim, Medical Oncologist at BC Cancer Agency – Vancouver
- Dr Dave Liu, Interventional Radiologist at University of British Columbia – Vancouver
- Dr Maged Nashed, Radiation Oncologist at University of Manitoba – Winnipeg
- Dr Jennifer Spratlin, Medical Oncologist at Cross Cancer Institute – Edmonton
- Dr Vincent Tam, Medical Oncologist at Tom Baker Cancer Centre – Calgary
Objectives
- Understand the current treatment landscape of intermediate HCC.
- Analyze the emerging role of systemic therapies in TACE/TARE-eligible intermediate HCC.
- Discuss the use of systemic therapy prior to liver transplant for intermediate stage HCC
patients. - Examine future directions and emerging therapies/treatment strategies in intermediate HCC.
Please RSVP here: https://forms.office.com/e/7qf5GTXZXu